WhatsApp, WeChat & Telegram : +8801886229488, Email : aiopharma@outlook.com
Aio Pharma
AIO Pharma is a supplier of generic cancer medicines made by licensed manufacturers in Bangladesh. We don’t manufacture. We source finished products directly from the makers, and each product page names the manufacturer. Message us on WhatsApp for prices, availability and delivery to your country.
Licensed manufacturers
High Quality
Worldwide delivery
Secure Payment
100% Secure Payment
30 Days Return
If goods have problems
24/7 Support
Dedicated support
Worldwide delivery
Worldwide delivery
Check out latest products
New Arrivals
-

Erdafixen 4mg (Erdafitinib): Targeted Treatment for FGFR-Altered Urothelial Cancer
-

Abemaxen® 150 mg (Abemaciclib) – A Trusted CDK4/6 Inhibitor for HR+ / HER2– Breast Cancer
-

Tizaro (Tirzepatide) Injection – Clinically Proven Weight Management Support
-

Fitaro (Semaglutide) – Clinically Proven Weight Management Support
-

Ivosenib 250 mg Ivosidenib
-


Bevacizumab (Bevixa) 100mg / 400mg
-

Apalutamide 60 mg (Prostaxen)
-


Mobocertinib 40 mg (Moboxen)
-

Brigatinib 180 mg (Briganix) | Break Free from Lung Cancer
-

Brigatinib 90 mg (Briganix) | The Power to Defeat Cancer
Check out popular products
Popular Products
-

Apalutamide 60 mg (Prostaxen)
-


Avalet 20 mg (Avatrombopag)
Rated 5.00 out of 5 -


Cabozantinib (Caboxen) 20/80 mg
-

Niraparib 100mg (Niranib): Unleashing Hope and Healing in Your Cancer Battle
-


Olaparib (Olanib) 50/150 mg
Rated 5.00 out of 5 -


Palbonix (Palbociclib) 100/125mg
-


Parib 50mg 150mg (Olaparib)
-


Ponaxen (Ponatinib) 15/45 mg
-


Rutinib Cream 30 gm Ruxolitinib Cream
Rated 5.00 out of 5 -


Sotorasib 120 mg (Stoxen)
Latest News

𝗔 𝗣𝗼𝘄𝗲𝗿𝗳𝘂𝗹 𝗩𝗶𝗱𝗲𝗼 𝗴𝗮𝗺𝗲 𝗳𝗼𝗿 𝗕𝗿𝗮𝗶𝗻 𝗛𝗲𝗮𝗹𝘁𝗵
The core idea is that video games that require physical exercise—a genre known as “exergaming”—do more…
- InUncategorized
- On

Russia’s “New Cancer Vaccine”: Breakthrough, Hype, or Something Else?
Headlines about a new “cancer vaccine” from Russia have been buzzing across news feeds and…
- InUncategorized
- On

Bangladesh Makes Strides in Biopharmaceutical Production with Bevixa, a Biosimilar to Avastin
In a significant step toward self-reliance in healthcare, Bangladesh has successfully developed and launched Bevixa,…
- InOncology
- On
Newsletter Updates
Subscribe to receive emails on new product arrivals & special offers
-


Osimert 80 mg (Osimertinib)
Rated 5.00 out of 5 -


Larotrectinib (Laronib 100mg/25mg)
Rated 5.00 out of 5 -


Avalet 20 mg (Avatrombopag)
Rated 5.00 out of 5
$110 ONLY!
Osimertinib
Osimertinib, sold under the brand name Tagrisso, is a medication used to treat non-small-cell lung carcinomas with specific mutations. It is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor.
